- Home
- CODI vs RCKT Comparison
CODI vs RCKT Comparison
Compare CODI & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CODI | RCKT |
|---|---|---|
| Founded | 2005 | 1999 |
| Country | United States | United States |
| Employees | N/A | 202 |
| Industry | Home Furnishings | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 480.8M | 401.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CODI | RCKT |
|---|---|---|
| Price | $10.30 | $3.43 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 14 |
| Target Price | $9.25 | ★ $29.73 |
| AVG Volume (30 Days) | 798.4K | ★ 3.1M |
| Earning Date | 05-06-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.25 | $64.28 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.58 | $2.53 |
| 52 Week High | $12.64 | $5.45 |
Technical Indicators
Market Signals| Indicator | CODI | RCKT |
|---|---|---|
| Relative Strength Index (RSI) | 49.49 | 46.97 |
| Support Level | $9.70 | $3.36 |
| Resistance Level | $11.85 | $3.56 |
| Average True Range (ATR) | 0.59 | 0.24 |
| MACD | 0.03 | -0.05 |
| Stochastic Oscillator | 30.51 | 19.91 |
Price Performance
Historical ComparisonAbout CODI D/B/A Compass Diversified Holdings Shares of Beneficial Interest
Compass Diversified Holdings is a diversified business conglomerate based in the United States having two groups: branded consumer business and industrial business. Branded consumer businesses are characterized as those businesses that capitalize on a valuable brand name in their respective market sector. It includes 5.11, Ergobaby, Liberty Safe, and Velocity Outdoor. Industrial businesses are characterized as those businesses that focus on manufacturing and selling particular products and industrial services within a specific market sector. The company has operations in the United States, Canada, Europe, Asia Pacific, and other International areas.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.